O-GlcNAcase
FunctionO-GlcNAcase or hyaluronoglucosaminidase (OGA) is one of two enzymes which modulate the level of O-linked N-acetylglucosamine (O-GlcNAc) attachment to cytoplasmic, nuclear and mitochondrial proteins[1]. The attachment of O-GlcNAc to proteins is a post-translational modification. RelevanceInhibition of OGA is a promising therapeutic approach to treat tau pathology in neurodegenerative diseases such as Alzheimer's disease and progressive supranuclear palsy[2]. The inhibition of OGA hinders formation of tau aggregates and decreases neuronal cell loss[3]. Structural highlightsThe 3D structure of the complex between human OGA and a transition state analog Thiamet-G shows the active site pocket at the base of a V-shaped cleft between the 2 OGA monomers. There are numerous H-bonds formed between OGA and Thiamet-G as well as some hydrophobic interactions. Two Asp residues are defined as catalytic residues[4].
| ||||||||||||
3D structures of O-GlcNAcase
Updated on 06-April-2026
- O-GlcNAcase
- 6hki, 5m7r - hOGA - human
- 9ne4, 9ne5, 9qen - hOGA – Cryo EM
- 5huk, 5uhp, 5vvo - hOGA TIM barrel 56-400 and stalk 544-705 domains
- 6r45 - OGA HAT-like domain 513-723 - Trichoplax adhaerens
- 2vur, 2v5c, 2v5d - CpOGA - Clostridium perfringens
- 2jh2 - CpOGA cohesin domain 768-909
- 2w1n - CpOGA cohesin+fibronectin domains 768-1001
- 9lr5 - BtOGA residues 22-737 (mutant) - Bacterioides thetaiotaomicron
- 2o4e - BtOGA residues 768-999 - NMR
- 2xsa - OgOGA - Oceanicola granulosus
- 6hki, 5m7r - hOGA - human
- O-GlcNAcase complex with small molecule
- 5m7u, 9ba9 - hOGA + inhibitor
- 6pm9, 5uhl - hOGA TIM barrel and stalk domains + inhibitor
- 5m7s - hOGA + transition state analog
- 5un9 - hOGA TIM barrel and stalk domains + transition state analog
- 5m7t - hOGA + PUGNAc derivative
- 5uho - hOGA TIM barrel and stalk domains + PUGNAc
- 5mi6 - hOGA + transition state analog + inhibitor
- 2j62 - CpOGA + GlcNAcstatin
- 2wb5, 2x0y, 2xpk, 5oxd - CpOGA + inhibitor
- 7khv - CpOGA (mutant) + pyrimidine derivative
- 2vvs, 2wca - BtOGA + PUGNAc
- 2j4g, 2w4x, 2vvn, 2w66, 2w67, 2xj7, 2xm1, 4aiu, 4ais, 2wzi, 2wzh, 4ur9, 5fky, 5fl0, 5fl1, 7ou6, 7ou8 - BtOGA + inhibitor
- 5mi4 - BtOGA (mutant) + inhibitor
- 2xm2 - BtOGA + LOGNAc
- 5abf, 5abg, 5abh, 5abe - BtOGA + pyrrolidine derivative
- 2jiw - BtOGA + epivalienamine derivative
- 2j47 - BtOGA + PUGNAc derivative
- 5mi5, 5mi7 - BtOGA + PUGNAc + inhibitor
- 2x0h - BtOGA + michaelis complex
- 2xsb - OgOGA + PUGNAc
- 7khs - OgOGA catalytic domain 1-447 + pyrimidine derivative
- 7k41 - EcOGA + inhibitor – Escherichia coli
- 5m7u, 9ba9 - hOGA + inhibitor
- O-GlcNAcase complex with polypeptide